Artwork

内容由n-Lorem Foundation and N-Lorem Foundation提供。所有播客内容(包括剧集、图形和播客描述)均由 n-Lorem Foundation and N-Lorem Foundation 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Better Health, Brighter Future for Rare with Dan Curran

29:52
 
分享
 

Manage episode 378782010 series 3349924
内容由n-Lorem Foundation and N-Lorem Foundation提供。所有播客内容(包括剧集、图形和播客描述)均由 n-Lorem Foundation and N-Lorem Foundation 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.

  • 2:02 How rare disease is defined at Takeda
  • 4:10 Rare disease units at Takeda
  • 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs
  • 9:06 The price of rare disease drugs is too high
  • 12:15 Why rare disease efforts are often associated with hematology
  • 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit
  • 16:42 Dr. Curran's professional journey
  • 20:50 Takeda's choice to support n-Lorem

  continue reading

55集单集

Artwork
icon分享
 
Manage episode 378782010 series 3349924
内容由n-Lorem Foundation and N-Lorem Foundation提供。所有播客内容(包括剧集、图形和播客描述)均由 n-Lorem Foundation and N-Lorem Foundation 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.

  • 2:02 How rare disease is defined at Takeda
  • 4:10 Rare disease units at Takeda
  • 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs
  • 9:06 The price of rare disease drugs is too high
  • 12:15 Why rare disease efforts are often associated with hematology
  • 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit
  • 16:42 Dr. Curran's professional journey
  • 20:50 Takeda's choice to support n-Lorem

  continue reading

55集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南